Future options in the treatment of giant cell arteritis

Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)

French protocol for the diagnosis and management of giant cell arteritis

Autologous Production: The Future of Sustainable Antibody Treatments

The role of senescence in polymyalgia rheumatica and giant cell arteritis

Concordance and agreement between different activity scores in polymyalgia rheumatica

Efficacy of Janus kinase inhibitors in rheumatoid arthritis

Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?

Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort

Towards a universal definition of disease activity score thresholds: the AS135 score

Hip Pain Associated with Acetabular Dysplasia in Patients with Suspected Axial Spondyloarthritis: DESIR Cohort Data

Fibroblasts, a target for imaging and therapeutics in rheumatoid arthritis

A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease

Aortic involvement in giant cell arteritis

Impact of the COVID-19 pandemic on therapeutic management of rheumatoid arthritis in Brittany (France)

The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle

Association of lumbosacral transitional vertebra and sacroiliitis in patients with inflammatory back pain suggesting axial spondyloarthritis

Associations of lumbar scoliosis with presentation of suspected early axial spondyloarthritis

Spinal-pelvic orientation: potential effect on the diagnosis of spondyloarthritis

A simplified radiographic score effectively predicts radiographic progression of early arthritis in a large nationwide French cohort

Anti-neutrophil cytoplasmic antibody-associated chronic inflammatory arthritis without vasculitis. Data from a French nationwide survey

What is the agreement between pathological features of parotid gland and labial salivary gland biopsies?

Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica

Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

[Cauda equina syndrome after Neisseria meningitidis type C meningitis]

Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study

Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's disease

Reliability Exercise of Ultrasound Salivary Glands in Sjögren's Disease: An International Web Training Initiative

Diagnostic utility of a second minor salivary gland biopsy in patients with suspected Sjögren's syndrome: A retrospective cohort study

Salivary gland ultrasonography in primary Sjögren's syndrome: opportunities and challenges

Against the dryness-an innovative 3D acini model to test new drugs in primary Sjögren's syndrome

Assessment of major salivary gland size in primary Sjögren's syndrome: Comparison between clinical examination and ultrasonography

The active immunological profile in patients with primary Sjögren's syndrome is restricted to typically encountered autoantibodies

Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort

Is there specific neurological disorders of primary Sjögren's syndrome?

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica

Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial

Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade

Tocilizumab controls bone turnover in early polymyalgia rheumatica

Abatacept Promotes Regulatory B Cell Functions, Enhancing Their Ability to Reduce the Th1 Response in Rheumatoid Arthritis Patients through the Production of IL-10 and TGF-β

Is Tocilizumab as efficient as steroids early in polymyalgia rheumatica?

Could abatacept directly target expanded plasmablasts in IgG4-related disease?

New onset of rheumatoid vasculitis during abatacept therapy and subsequent improvement after rituximab

Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry

Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial

Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy

Prevalence and predictors of atlanto-axial subluxation in rheumatoid arthritis after 12-years' follow-up (ESPOIR Cohort)

Could abatacept directly target expanded plasmablasts in IgG4-related disease?

Impact de la pandémie à COVID-19 sur la prise en charge thérapeutique des patients présentant une polyarthrite rhumatoïde en Bretagne (France)

The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials

The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials